Based in the United States, Freespira is a startup. Brouky records 1 investor associated with the company.
Freespira develops an FDA-cleared, medication-free digital therapeutic that delivers a 28-day treatment shown to reduce or eliminate symptoms of panic disorder, panic attacks, and post-traumatic stress disorder. Its solution is used by health plans, providers, and self-insured employers to support mental health care and resource utilization.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.